Area description
 
 
Long description
Short description

 

Grupo de Investigación
 
 
Coordinadora del Área:
 

Personal Investigador:
Ana Torrella
Carmen Alberic
Carolina Chaparro
Cristóbal Llorens
Dolores Salas
Elena Pérez
Inmaculada Martinez
Lola Cuevas
Marisa Vicente
Maria José Valverde
Mercedes Vanaclocha
Pepa Miranda
Pepa Ibáñez
Rosana Peiró
Susana Castany
Xelo Sabater
Vicent Villanueva
 

Historial del Grupo Investigación
 

 

Cancer and Public Health
 
 

 

Objectives
 

In Europe, 3.2 million people are diagnosed with cancer every year (mainly colorectal, breast and lung cancer). Despite significant advances in research and treatment, cancer still remains a significant health problem. Cancer is one of the main health problems in the Valencian region and therefore represents one of the main priorities oft the health system, as shown in the Plan de Salud. It is the second most common cause of death, leading to 28.1% of deaths in males and 19.1% in women. It is also the cause of 10% of admissions in public hospitals.

This has lead to the development of the Oncology Plan, with one of its main areas dedicated to cancer research. The battle against cancer involves several lines of action: identifying the causes of cancer, eliminating or reducing exposure to known risk factors, detecting cancer at an early stage by means of screening and improving treatment and patient care.

     

 

Lines of Research

1. Research and evaluation of cancer control prevention strategies

This line aims to identify, analyse and evaluate the impact of different policies and interventions, taking place outside the health sector, on cancer. It aims to analyse the risk factors associated with cancer, and develop new intervention methods to promote a cancer-free life for a longer period of time. It also identifies environmental and occupation exposure related to the development of cancer.

2.  Research and evaluation of cancer control strategies: secondary prevention of cancer

This line has two main areas. The first area involves close analysis of prevention strategies and the control of screening side effects, as well as strategies for quality control in screening. The second area aims to contribute to the identification of new effective screening examinations for cancer screening of average or high risk populations.
 

3. Cancer and Health Services

This line analyses developments in the health services related to screening programmes and other health care provisions for cancer care. It also evaluates the patient quality of life and satisfaction. Systematic checks are carried out to produce oncology guides and to evaluate their impact in the health service. It evaluates the cancer care process. We are currently starting a new line of research into how to better inform the population about screening examinations and alternative treatment, in addition to addressing the uncertainty surrounding this issue.

4. Monitoring cancer. The impact of interventions on cancer


This line aims to evaluate the specific indicators and impact of cancer screening programmes. It analyses the information systems available that can provide information to describe, monitor and evaluate the status of cancer. It conducts studies on rates of survival by using tumour records.
 

5. Inequalities in health and cancer


This line incorporates the study and analysis of both social and gender inequality into all areas of research. However, it will be worked into specific lines of research to better understand questions of inequality and cancer. Specific lines are developed to investigate the distribution of known risk factors for cancer according to socioeconomic status, the use of screening services according to socioeconomic status and the unequal use of these services according to gender.
 


 
 

CanCon Project

Website CanCon